A Study to Identify Genetic Markers in Non-Cancerous Prostate Tissues, and Compare to Better Identify the Markers Unique to Prostate Cancer

Overview

About this study

The purpose of this study is to identify DNA methylation (genetic) markers in non-cancerous prostate tissue, and compare with the markers previously found to be in prostate cancer tissue. This will provide data that can be used to identify genetic marker profiles to diagnose and provide prognosis for prostate cancer.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Male
Scheduled for a transurethral prostatectomy enucleation
No cancer identified in prostate

Exclusion Criteria

Has prostate cancer

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Matthew Gettman, M.D.	Closed for enrollment	Contact information: Karen Doering M.B.A., CCRP (507) 538-0096 Doering.Karen@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Gettman, M.D.

Closed for enrollment

Contact information:

Karen Doering M.B.A., CCRP

(507) 538-0096

Doering.Karen@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials